Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Download citation(s)

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?

Alexander Tenenbaum email and Enrique Z Fisman email

Cardiovascular Diabetology 2004, 3:10doi:10.1186/1475-2840-3-10

Include Article citation and all cited references
Cited references only
Article citation only
Format EndNote, Zotero or Papers
Reference Manager
Refworks
BibTex
Direct import
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.